[1]苏杉,王蓉,赵敏,等.秦艽寒热不同配伍对风寒湿痹类风湿关节炎大鼠白细胞介素-6及血管内皮生长因子的影响[J].中国中医药信息杂志,2019,26(3):39-44.[doi:10.3969/j.issn.1005-5304.2019.03.010]
 SU Shan,WANG Rong,ZHAO Min,et al.Effects of Different Compatibility of Gentianae Macrophyllae Radix on IL-6 and Vascular Endothelial Growth Factor in Rheumatoid Arthritis Rats with Wind-cold-dampness Arthralgia[J].zhongguo zhongyiyao xinxi zazhi,2019,26(3):39-44.[doi:10.3969/j.issn.1005-5304.2019.03.010]
点击复制

秦艽寒热不同配伍对风寒湿痹类风湿关节炎大鼠白细胞介素-6及血管内皮生长因子的影响

参考文献/References:

[1] 于天一,孔庆喜,陈丽姝,等.类风湿关节炎的病理机制浅析[J].黑龙江医药,2014,27(1):98-102.
[2] SZEKANECZ Z,KOCH A E. Targeting an giogenesis in rheumatoid arthritis[J]. Curr Rheumatol Rev,2008,4(4):298-303.
[3] 高慧琴,吴国泰,孙少伯,等.秦艽不同配伍对风湿痹证模型大鼠血清炎症因子水平的影响[J].中医杂志,2013,54(9):785-788.
[4] 高慧琴,吴国泰.秦艽不同配伍的抗炎镇痛作用[J].中国实验方剂学杂志,2010,16(9):182-183.
[5] 程仕萍,贾冬梅,周平生,等.基于文本挖掘的中医药治疗类风湿关节炎骨破坏用药规律[J].中医杂志,2016,57(11):970-974.
[6] 王颖,郑炜,刘小平,等.基于中医传承辅助平台的中医药治疗类风湿关节炎用药规律分析[J].中国实验方剂学杂志,2016,22(23):181-186.
[7] 柳春,梁永林,姚柳伊.类风湿关节炎寒湿痹阻证用药规律研究[J].中国中西医结合杂志,2013,33(9):1269-1272.
[8] 赵建萍,赵秀娟,陈谢谢,等.中药治疗类风湿关节炎的常用药分析[J].医药论坛杂志,2017,38(9):5-7.
[9] 张华东.对类风湿关节炎发病机制的认识[N].中国中医药报, 2003-03-03(03).
[10] DIENZ O, EATON S J, NEVEU W, et al.The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+T cells[J]. Journal of Experimental Medicine,2009,206:69-78.
[11] YOUINOU P, JAMIN C. The weight of interleukin-6 in B cell-related autoimmune disorders[J]. Journal of Autoimmunity, 2009,32(3/4):206.
[12] 苗平,陆梅生,张冬青.IL-6/IL-6受体与类风湿关节炎关联性研究新进展[J].免疫学杂志,2011,27(4):355-360.
[13] 毛丹青,朱爱玲,童巧薇,等.妊娠高血压疾病患者治疗前后血清白介素-6、8、10水平的变化[J].中国现代医生,2013,51(28):40-41.
[14] 赵璐.IL-6/STAT3信号传导通路及其在肿瘤靶向治疗的研究进展[J].中外医学研究,2012,10(14):144-146.
[15] 储永良,黄清春.血管内皮生长因子及其受体对类风湿关节炎新生血管的影响[J].中国组织工程研究,2005,9(39):142-144.
[16] 黄佩琼,李龙.类风湿关节炎发病期间血管内皮生长因子与白介素的作用研究进展[J].中外医学研究,2016,14(33):156-157.
[17] 陈勇,黄娴倩,陈立斌,等.类风湿关节炎患者超声评估滑膜病变与血清血管内皮生长因子检测的相关性研究[J].现代实用医学,2011,23(9):973-976.
[18] LEE S S, JOO Y S, KIM W U, et al. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis[J]. Clinical & Experimental Rheumatology, 2001,19(3):321-324.
[19] BANDT M D, MAHDI M H B, OLLIVIER V, et al. Blockade of vascular endothelial growth factor receptor Ⅰ (VEGF-RⅠ),but not VEGF-RⅡ, suppresses joint destruction in the K/BxN model of rheumatoid arthritis[J]. Journal of Immunology,2003,171(9):4853-4859.(收稿日期:2018-06-29)(修回日期:2018-07-31;编辑:华强)

相似文献/References:

[1]周玉珊,张西玲,汪荣斌,等.甘肃产秦艽与黄管秦艽微量元素的比较研究[J].中国中医药信息杂志,2008,15(2):34.
 ZHOU Yu-shan,ZHANG Xi-ling,WANG Rong-bin,et al.Comparative Study on Trace Elements in Gentiana macrophlla and Gentiana officinalis from Gansu[J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):34.
[2]李佳峰,岳明,魏朔南.秦艽等龙胆属植物中龙胆苦苷含量测定及其与土壤元素和pH值相关性研究[J].中国中医药信息杂志,2012,19(10):50.[doi:10.3969/j.issn.1005-5304.2012.10.020]
 LI Jia-feng,YUE Ming,WEI Shuo-nan.Detemination of Gentiopicroside in Gentiana macrophylla Pall and Relative Species and Its relation with Soil Element and pH[J].zhongguo zhongyiyao xinxi zazhi,2012,19(3):50.[doi:10.3969/j.issn.1005-5304.2012.10.020]
[3]呼延玲,解 娟,陈世虎.高效液相色谱法测定秦艽不同部位龙胆苦苷的含量[J].中国中医药信息杂志,2005,12(10):38.
 HU Yan-ling,XIE Juan,CHEN Shi-hu.Determination of the Content of Gentiopicrin for Gentiana macrophylla Pall's Different Parts by HPLC[J].zhongguo zhongyiyao xinxi zazhi,2005,12(3):38.
[4]吕 萍,龙新生,王菊萍,等.护肾痛风泰颗粒的质量控制[J].中国中医药信息杂志,2004,11(4):315.
 LU Ping,LONG Xin-Sheng,WANG Ju-Ping,et al.The Quality Control of Hushen Tongfengtai Granules[J].zhongguo zhongyiyao xinxi zazhi,2004,11(3):315.

备注/Memo

基金项目:国家自然科学基金(81360648)

更新日期/Last Update:

2019-02-28